APA (7th ed.) Citation

AM, G., DC, H., LP, V., Y, G., OM, M., CA, Y., . . . P, A. (2025). Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: The DELI transition trial. Diabetologia, 68(9), 1899. https://doi.org/10.1007/s00125-025-06446-y

Chicago Style (17th ed.) Citation

AM, Gómez-Medina, Henao-Carillo DC, Villamil-Castañeda LP, Gómez-Quesada Y, Muñoz-Velandia OM, Yepes CA, Chaim SN, Pertuz-Noriega CE, and Aschner P. "Insulin DEgludec/LIraglutide Versus Multiple Daily Insulin Injections in the Transition from Hospital to Outpatient Management Assessed by Continuous Glucose Monitoring: The DELI Transition Trial." Diabetologia 68, no. 9 (2025): 1899. https://doi.org/10.1007/s00125-025-06446-y.

MLA (9th ed.) Citation

AM, Gómez-Medina, et al. "Insulin DEgludec/LIraglutide Versus Multiple Daily Insulin Injections in the Transition from Hospital to Outpatient Management Assessed by Continuous Glucose Monitoring: The DELI Transition Trial." Diabetologia, vol. 68, no. 9, 2025, p. 1899, https://doi.org/10.1007/s00125-025-06446-y.